ALDX
Price
$4.84
Change
+$0.06 (+1.26%)
Updated
Jan 17 closing price
Capitalization
288.22M
46 days until earnings call
PHAT
Price
$6.96
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
475.91M
44 days until earnings call
Ad is loading...

ALDX vs PHAT

Header iconALDX vs PHAT Comparison
Open Charts ALDX vs PHATBanner chart's image
Aldeyra Therapeutics
Price$4.84
Change+$0.06 (+1.26%)
Volume$274.81K
Capitalization288.22M
Phathom Pharmaceuticals
Price$6.96
Change-$0.00 (-0.00%)
Volume$754.61K
Capitalization475.91M
ALDX vs PHAT Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. PHAT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and PHAT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ALDX: $4.84 vs. PHAT: $6.96)
Brand notoriety: ALDX and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 57% vs. PHAT: 69%
Market capitalization -- ALDX: $288.22M vs. PHAT: $475.91M
ALDX [@Biotechnology] is valued at $288.22M. PHAT’s [@Biotechnology] market capitalization is $475.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • PHAT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -2.02% price change this week, while PHAT (@Biotechnology) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ALDX is expected to report earnings on May 01, 2025.

PHAT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($476M) has a higher market cap than ALDX($288M). ALDX YTD gains are higher at: -3.006 vs. PHAT (-14.286). ALDX has higher annual earnings (EBITDA): -42.57M vs. PHAT (-272.21M). PHAT has more cash in the bank: 335M vs. ALDX (113M). ALDX has less debt than PHAT: ALDX (15.6M) vs PHAT (176M). PHAT has higher revenues than ALDX: PHAT (26.3M) vs ALDX (0).
ALDXPHATALDX / PHAT
Capitalization288M476M61%
EBITDA-42.57M-272.21M16%
Gain YTD-3.006-14.28621%
P/E RatioN/AN/A-
Revenue026.3M-
Total Cash113M335M34%
Total Debt15.6M176M9%
FUNDAMENTALS RATINGS
ALDX: Fundamental Ratings
ALDX
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALDXPHAT
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
89%
Momentum
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 6 days ago
80%
MACD
ODDS (%)
Bearish Trend 6 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 24 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
88%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 6 days ago
83%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+1.26%
GSGTF - ALDX
56%
Loosely correlated
N/A
FOLD - ALDX
43%
Loosely correlated
+0.53%
ATAI - ALDX
43%
Loosely correlated
+5.04%
ABSI - ALDX
43%
Loosely correlated
+3.57%
ROIV - ALDX
41%
Loosely correlated
+2.39%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TCRX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
N/A
TCRX - PHAT
35%
Loosely correlated
-2.44%
ALDX - PHAT
31%
Poorly correlated
+1.26%
TSHA - PHAT
30%
Poorly correlated
-3.16%
OTLK - PHAT
29%
Poorly correlated
+1.83%
ABOS - PHAT
29%
Poorly correlated
+2.48%
More